Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer

BACKGROUND: Intravesical Bacilli Calmette-Guerin (IVBCG) therapy for non-muscle invasive bladder cancer (NMIBC) has long been in use successfully. Albeit rarely, we still face with its safety concerns more than 25 years on since its approval by US Food and Drug Agency in 1990. Local and systemic inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Azharuddin, Arastu, Zubair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719568/
https://www.ncbi.nlm.nih.gov/pubmed/29212486
http://dx.doi.org/10.1186/s12894-017-0304-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719568/
https://www.ncbi.nlm.nih.gov/pubmed/29212486
http://dx.doi.org/10.1186/s12894-017-0304-5

Ejemplares similares